Dr. Robert Pearl believes tools like ChatGPT will make patients healthier, providers happier, and medical bills smaller
Every year, an estimated 800,000 Americans die or are permanently disabled after a medical misdiagnosis. More than a million die as a result of complications from manageable chronic diseases such as diabetes and hypertension.
Dr. Robert Pearl, former CEO of the Permanente Medical Group, has traced these dismal outcomes to a toxic culture among doctors and a broken healthcare system that puts corporate profits above patients’ well-being.
Now, he believes, a remedy has arrived: generative artificial intelligence, the deep learning models that draw on huge quantities of information to answer complex questions in the blink of an eye. “I see it as the holy grail we have wanted for almost a century,” says Pearl, a lecturer in organizational behavior at Stanford Graduate School of Business and a clinical professor of plastic surgery at Stanford University School of Medicine. In his new book, ChatGPT, MD — written with assistance from OpenAI’s popular chatbot — Pearl argues that this technology stands apart from previous innovations because it goes beyond democratizing knowledge by offering personalized expertise that will give patients better outcomes and make doctors’ and nurses’ jobs less stressful.
Stanford Business spoke with Pearl about how he thinks generative AI will transform medicine for the better.
In your book, you describe a case that haunted you from your time as a practicing plastic surgeon. You and your colleagues diagnosed a massive bump on a newborn’s neck as a benign lymphangioma, but it turned out to be a rare and aggressive form of cancer. You regretted not performing a biopsy sooner. How could generative AI have prevented this situation?
This piece originally appeared in Stanford Business Insights from Stanford Graduate School of Business. To receive business ideas and insights from Stanford GSB click here: (To sign up: https://www.gsb.stanford.edu/insights/about/emails)